Introduction {#j_bjmg-2016-0011_s_001}
============

Krabbe disease or globoid-cell leukodystrophy, is an autosomal recessive lysosomal disorder that affects the white matter of both central and peripheral nervous systems. It is the result of a deficiency of the lysosomal enzyme β-galactocerebrosidase (galactosylceramidase, β-GALC or, in very few cases, it is due to lack of activator saposin A (sphingolipid activator protein) \[[@j_bjmg-2016-0011_ref_001]-[@j_bjmg-2016-0011_ref_003]\]. The gene encoding β-GALC has been mapped to 14q31. This gene, located on chromosome 14q31, encodes the β-GALC protein, which has a hydrolase function critical for glycosphingolipid catabolism. To date, more than 130 mutations of the *GALC* gene have been listed in the Human Gene Mutation Database (HGMD) \[[@j_bjmg-2016-0011_ref_001]-[@j_bjmg-2016-0011_ref_003]\]. The early infantile form of the Krabbe disease is the most common (85.0-90.0% of all cases), with onset in the early infantile period (before the age of 6 months), and a clinical picture characterized by hyperirritability and psychomotor deterioration often associated with episodes of fever, while many patients develop peripheral neuropathy with decreased nerve conduction velocities (NCVs) \[[@j_bjmg-2016-0011_ref_001]-[@j_bjmg-2016-0011_ref_003]\]. We report clinical, neuroradiological, neurophysiological and molecular findings of two Greek patients with the infantile form of Krabbe disease.

Case Reports {#j_bjmg-2016-0011_s_001_s_001}
------------

The first patient was admitted at the age of 3.5 months, due to generalized hypertonia. He is the fourth child of healthy, non consanguineous parents of Caucasian origin. One of his siblings, a male infant died at the age of 7 months, presumably due to cerebral atrophy and epilepsy, without a specific diagnosis. The other two siblings are healthy females, 13 and 8 years old, respectively.

The patient was delivered normally after an uneventful gestation at 40 weeks. Generalized hypertonia was evident already from the first month of life, according to the family pediatrician.

Physical examination on admission revealed short stature (below the 3rd percentile), severe hypertonia of all extremities, absence of head control, opisthotonus, fisted hands and pyramidal tract signs with increased deep tendon reflexes, positive Rossolimo reflexes and clonus bilaterally. Additionally, a mild convergent squint was noted, with normal reaction to visual and auditory stimuli.

Magnetic resonance imaging (MRI) of the patient's brain demonstrated abnormal signal of the deep white matter of the cerebellum, the middle cerebellar peduncles and probably the pyramidal tracts of the medulla oblongata. Additionally, there was a mild enlargement of the subarachnoid spaces and an increased signal of the posterior limbs of the internal capsule bilaterally and the white matter of the occipital lobes ([Figure 1](#j_bjmg-2016-0011_fig_001){ref-type="fig"}). Electroencephalogram, visual and brainstem auditory evoked potentials, demonstrated normal findings. Both motor and sensory NCVs were significantly decreased ([Table 1](#j_bjmg-2016-0011_tab_001){ref-type="table"}) with normal compound action potentials, suggestive of demyelination.

![Brain MRI of the first patient at the age of 3.5 months (T2 weighted sequences TR/TE 4000/99). Note the mildly increased signal in the posterior limbs of the internal capsule bilaterally and in the white matter of the occipital lobe.](j_bjmg-2016-0011_fig_001){#j_bjmg-2016-0011_fig_001}

###### 

Nerve conduction velocities in both patients.

                                 Nerve Conduction Velocities (m/s)                               
  ------------------------------ ----------------------------------- ------ ------ ------ ------ ------
  Patient 1                      4 months                            28.2   25.0   21.4   18.7   33.2
  Normal values for 1-6 months                                       33.3   35.0   35.0   38.8   40.6
  Patient 2                      18 months                           30.2   31.8   29.2   34.6   29.4
  Normal values for 1-2 years                                        53.6   52.2   50.2   51.4   53.0

Normal values (represent the lower normal limit \[mean ± 2 standard deviation (SD)\] for NCV at the age of 4 months in our laboratory.

Cerebrospinal fluid (CSF) protein was clearly elevated (80 mg/dL; normal values \<10). A subsequent screening for lysosomal enzymes in leukocytes (at the Department of Enzymology, Institute of Child Health, Athens, Greece) demonstrated increased chitotriosidase activity (1566 nmol/mL/hour, normal range 0-150) and a severe reduction of β-GALC activity (0.003 nmol/mg protein/hour, normal range 0.1-0.97), whereas the activities of α-N-acetylglycosaminidase, β-galactosidase and β-hexosaminidase were normal.

The above biochemical findings were suggestive of Krabbe disease, a diagnosis that was confirmed by molecular genetic testing (at the Department of Genetics, Universitat de Barcelona & Neurogenetics, Barcelona, Spain, and the Metabolic Disorders Unit, University of Rostock, Rostock, Germany). The latter revealed a homozygous c.411_413 delTAA \[p.K139del\] deletion on the *GALC* gene.

The patient's further course was downhill with further deterioration. At the last follow-up visit at the age of 4 years, he was bed-ridden and quadriplegic, suffering from frequent infections of the respiratory tract and fed through a gastrostomy catheter. Moreover, he demonstrated uncoordinated eye movements without visual contact.

The second patient was transferred to a tertiary pediatric hospital at the age of 18 months, due to generalized hypertonia and seizures. He is the only child of healthy, non consanguineous parents of Caucasian origin delivered normally after an uneventful 40 weeks' gestation. His psychomotor development was normal until the age of 6 months, when he started deteriorating in terms of motor skills, and 4 months later, a generalized hypertonia was evident. The brain MRI showed mild enlargement of both Sylvian fissures, the subarachnoid spaces of the frontal convexities and the interhemispheric fissure, as well as an increased signal of the periventricular white matter. According to the neuroradiologist, the constellation of the above findings were compatible with a delayed myelination; however, the possibility of a leukoencephalopathy could not be entirely ruled out. Due to the above findings, physical and occupational therapy were initiated.

At the age of 18 months, he manifested a generalized status epilepticus. On admission he was febrile, somnolent and had mild respiratory distress. Physical examination revealed tonsillitis. Kernig and Brudzinski signs were negative. Neurological examination revealed generalized hypertonia with fisted hands, absent pupillary light reflex, response solely to painful stimuli, nystagmus, increased deep tendon reflexes, positive Babinski sign, Rossolimo reflex and clonus bilaterally.

Examination of the fundus revealed nonresponsive pupils without papilledema, while the electroencephalogram disclosed multifocal spikes and sharp waves. Brainstem auditory evoked and visual evoked potentials were normal. Motor and sensory NCVs were significantly delayed with normal compound action potentials, consistent with peripheral demyelination ([Table 1](#j_bjmg-2016-0011_tab_001){ref-type="table"}).

A repeated brain MRI performed at the time ([Figure 2](#j_bjmg-2016-0011_fig_002){ref-type="fig"}), demonstrated increased signal of the white matter around the occipital horns of the lateral ventricles with enlargement of lateral ventricles and the subarachnoid spaces bilaterally. These lesions of the white matter expanded radially, while additional small lesions in the anterior fiber bundles of the pons and the brainstem.

![Brain MRI of second patient at the age of 18 months (T2 weighted sequences TR/TE 4510/119). Note the increased signal in the periventicular white matter around the occipital horns of the lateral ventricles with enlargement of both lateral ventricles and the subarachnoid spaces.](j_bjmg-2016-0011_fig_002){#j_bjmg-2016-0011_fig_002}

Cerebrospinal fluid protein at that time point was clearly elevated (110 mg/dL; normal values \<10). A subsequent screening for lysosomal enzymes in leukocytes (at the Department of Enzymology, Institute of Child Health, Athens, Greece) demonstrated mildly increased chitotriosidase activity (217 nmol/nl/hour, normal range 0-150) and a total lack of β-GALC activity (0.00 nmol/mg protein/hr, normal range 0.1--0.97), whereas the activities of arylsulphatase A, β-galactosidase and β-hexosaminidase were normal.

The total lack of β-GALC activity was confirmed in a second assay, thus pointing to the diagnosis of Krabbe disease. The final diagnosis was established by further molecular genetic testing (at the Department of Genetics, Universitat de Barcelona & Neurogenetics, Barcelona, Spain, and the Metabolic Disorders Unit, University of Rostock, Rostock, Germany), which revealed the presence of the a homozygous p.I250T (c.749T\>C) mutation on the *GALC* gene, with both parents being carriers.

On follow-up at 6 years of age, the patient was bedridden and quadriplegic with optic atrophy and contractures of the lower extremities, despite receiving regular physical therapy. His seizure disorder was well controlled under treatment with levatiracetam.

Discussion {#j_bjmg-2016-0011_s_002}
==========

Krabbe disease (also known as globoid cell leukodystrophy, GCL; OMIM \#245200) is a rare inherited lysosomal storage disorder, with a pathology not completely elucidated. It is caused by a deficiency of β-GALC (E.C. 3.2.1.46), a lysosomal enzyme involved in the catabolism of galactosylceramide. The deficiency of β-GALC impairs the degradation of a major myelin lipid, galactocerebroside with the subsequent accumulation of a cytotoxic compound, galactosylsphingosine, also called psychosine \[[@j_bjmg-2016-0011_ref_004]\]. The excess of galactosylceramide elicits the formation of multinucleated macrophages, the globoid cells. Progressive accumulation of psychosine could explain the prominent death of oligodendrocytes, thus contributing to progressive demyelination \[[@j_bjmg-2016-0011_ref_005]\].

Krabbe disease is usually diagnosed before the first year of life, because of the early onset of developmental delay or regression, limb spasticity and extreme irritability \[[@j_bjmg-2016-0011_ref_002]\]. Optic atrophy and sluggish pupillary reactions to light are common \[[@j_bjmg-2016-0011_ref_002],[@j_bjmg-2016-0011_ref_006],[@j_bjmg-2016-0011_ref_007]\]. Children with Krabbe disease generally experience severe neurological deterioration and death before 2 years of age, although prolonged survival has been reported.

Both index cases could be classified as infantile onset globoid-cell leukodystrophy \[[@j_bjmg-2016-0011_ref_002],[@j_bjmg-2016-0011_ref_005]\], with a disease onset at 3.5 and 6 months of age, respectively, and a rather typical constellation of clinical findings (developmental delay with subsequent regression, spasticity and optic atrophy) and neuroradiological findings (deep white matter leuko-dystrophic alterations). However, it is worth noticing that the second patient's brain MRI at presentation was deceptively normal, a finding already reported in the literature \[[@j_bjmg-2016-0011_ref_008]\], underpinning the need for further biochemical work-up, even in the absence of associated brain MRI findings, in infants with unexplained developmental delay and/or regression.

Multimodal evoked potentials in the early infantile form of Krabbe disease are considerably abnormal at pronounced stages of the disease \[[@j_bjmg-2016-0011_ref_001],[@j_bjmg-2016-0011_ref_005],[@j_bjmg-2016-0011_ref_008]\]. In both reported patients, brainstem auditory and visual evoked potentials were normal at the age of diagnosis. On the contrary, decreased NCVs of all examined nerves (motor and sensory) was demonstrated, without however reaching the markedly reduced values observed in late infantile Krabbe disease \[[@j_bjmg-2016-0011_ref_009]\]. To the best of our knowledge, serial NCV findings in early-infantile Krabbe disease have previously been reported in another Greek case by Zafeiriou *et al*. \[[@j_bjmg-2016-0011_ref_008]\], while a mild increase in polyphasic motor unit potentials, as demonstrated by electromyography, was reported by Hogan *et al*. \[[@j_bjmg-2016-0011_ref_010]\].

Most patients with Krabbe disease, irrespective of type and age at onset, demonstrate a severe deficiency in β-GALC activity, as measured in leukocytes isolated from whole blood or alternatively in cultured skin fibroblasts \[[@j_bjmg-2016-0011_ref_011]\]. Since the cloning of the human *GALC* gene on chromosome 14q31 in 1993 \[[@j_bjmg-2016-0011_ref_002]\], over 130 mutations have been described \[[@j_bjmg-2016-0011_ref_002],[@j_bjmg-2016-0011_ref_012]\]. Different kinds of genetic alterations have been reported: missense/nonsense mutations, deletions, splice mutations, insertions and duplications \[[@j_bjmg-2016-0011_ref_002]\]. According to one of the largest genotypic analyses of the *GALC* gene performed in a European cohort of patients with Krabbe disease, the GALC mutational profile in European patients differs from other cohorts; thus, the most common large deletion, c.1161+6532 plus three additional mutations \[c.1586C\>T, c.1700C\>T, c.1472delA (1538 C\>T, 1652A\>C, 1424delA)\], together account for about 60.0% of patients of European origin with the classic infantile form \[[@j_bjmg-2016-0011_ref_011]\].

In the index patients, the mutation analysis of the *GALC* gene revealed two different mutations in a homozygous state, the c.749T\>C \[p.I250T\] mutation and the c.411_413 delTAA \[K139del\] mutation. A thorough literature search disclosed five patients carrying the c.749T\>C \[p.I250T\] mutation. In the first of those patients, classified as having early infantile Krabbe disease, the latter mutation was found in a heterozygous state and associated with the rare finding of optic nerve enlargement \[[@j_bjmg-2016-0011_ref_013]\], as well as in two other patients associated with neonatal and infantile onset of the disease, respectively \[[@j_bjmg-2016-0011_ref_012]\]. The above mutation in homozygosity was associated with late infantile Krabbe disease, in a female patient born to consanguineous parents and manifesting with motor regression and peripheral neuropathy \[[@j_bjmg-2016-0011_ref_008],[@j_bjmg-2016-0011_ref_013]\], as well as in four additional patients with early-onset disease \[[@j_bjmg-2016-0011_ref_010]\]. Interestingly, some of these patients were of Greek ancestry \[[@j_bjmg-2016-0011_ref_011],[@j_bjmg-2016-0011_ref_012]\], as our index cases.

Regarding the second mutation, the c.411_413delTAA \[K139del\], it has recently been described in two Greek siblings with late-onset slowly progressive disease \[[@j_bjmg-2016-0011_ref_012]\]. Moreover, the same mutation has been described in a heterozygous state in an adult patient of Turkish origin \[[@j_bjmg-2016-0011_ref_005]\]. These data allow the assumption that the latter mutation in a homozygous state could be associated with more severe and earlier-onset forms of the disease, while the heterozygous state could be associated with a later-onset and more protracted clinical course.

Further studies are needed in order to elucidate the genetic landscape and the clinical importance of specific mutations, as a genotype-phenotype correlation relationship in Krabbe disease still remains unclear. This would make it possible to be able to offer more accurate genetic counseling and suggest either prenatal diagnosis or pre-implantation genetics to the affected families \[[@j_bjmg-2016-0011_ref_014]\].

In conclusion, we have presented brain MRI, neuro-physiological and genetic findings in two additional Greek cases of early-infantile Krabbe disease. The above report with the identified mutations add to the pathogenic mutation database of the *GALC* gene and may increase public awareness of Krabbe disease in Greece and elsewhere. Genotyping of patients with Krabbe disease is important, in order to contribute to the development of a European mutation database and to further study possible genotype-phenotype correlations of the disease.
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